Immucell (ICCC) Net Margin (QoQ) (2010 - 2025)
Immucell (ICCC) Net Margin (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - |
| 10 | Immucell | 93.37 Mn | 84.51 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,482.00 |
| Sep 30, 2025 | -1,033.00 |
| Jun 30, 2025 | -1,015.00 |
| Mar 31, 2025 | 1,130.00 |
| Dec 31, 2024 | 1,831.00 |
| Sep 30, 2024 | 253,133.00 |
| Jun 30, 2024 | -253,697.00 |
| Sep 30, 2023 | 2,164.00 |
| Jun 30, 2023 | 2,811.00 |
| Mar 31, 2023 | -2,594.00 |
| Dec 31, 2022 | -2,757.00 |
| Sep 30, 2022 | -170.00 |
| Jun 30, 2022 | -2,051.00 |
| Mar 31, 2022 | 719.00 |
| Dec 31, 2021 | -151.00 |
| Sep 30, 2021 | -24.00 |
| Jun 30, 2021 | 1,385.00 |
| Mar 31, 2021 | -1,540.00 |
| Dec 31, 2020 | 1,333.00 |
| Sep 30, 2020 | 1,715.00 |